The Future of PSMA-Targeted Radionuclide Therapy: An Overview of Recent Preclinical Research

Prostate specific membrane antigen (PSMA) has become a major focus point in the research and development of prostate cancer (PCa) imaging and therapeutic strategies using radiolabeled tracers. PSMA has shown to be an excellent target for PCa theranostics because of its high expression on the membran...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruigrok, Eline A.M., van Weerden, Wytske M., Nonnekens, Julie, de Jong, Marion
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6921028/
https://www.ncbi.nlm.nih.gov/pubmed/31671763
http://dx.doi.org/10.3390/pharmaceutics11110560

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6921028/
https://www.ncbi.nlm.nih.gov/pubmed/31671763
http://dx.doi.org/10.3390/pharmaceutics11110560

Ejemplares similares